The GMC Sierra Denali arrived near the start of Y2K, and with it came a game-changing notion: what if hard-working capability ...

Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.

YUKON DENALI 以其霸气的外观、强大的性能和极致的奢华，成为了好莱坞明星们的传奇座驾。它不仅是一款交通工具，更是一种身份与品味的象征。无论是在繁华的都市街头，还是在星光熠熠的红毯上，YUKON DENALI ...

根据提交给美国证券交易委员会的文件显示，Denali Therapeutics Inc. (NASDAQ:DNLI)的首席医疗官Carole Ho最近出售了公司的普通股。1月6日和7日，Ho总共出售了15,162股，获得308,290美元。售价在每股20.22美元至20.81美元之间。根据 InvestingPro ...

分析师评论了Denali最近的股价下跌，将其归因于更广泛的市场趋势，而非公司特定消息。Denali的股价回调反映了XBI生物技术指数的走势，被认为是整体投资组合定位转变的一部分，在高利率环境下，较大的基金可能减少了生物技术领域的敞口。

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing ...

Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...

AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

To commemorate the 25th anniversary of Denali, GMC is offering customers a special 25th Anniversary Denali Package available ...